These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6304936)

  • 1. Influence of food on the clinical effect of angiotensin I converting enzyme inhibitor (SQ 14,225).
    Izumi Y; Honda M; Hatano M; Kawahara Y
    Tohoku J Exp Med; 1983 Mar; 139(3):279-86. PubMed ID: 6304936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between blood pressure and blood levels of angiotensin I converting enzyme inhibitor (SQ 14,225).
    Honda M; Izumi Y; Kawahara Y; Hatano M
    Jpn Circ J; 1981 Sep; 45(9):1025-9. PubMed ID: 7029028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response in captopril therapy of hypertension.
    Lijnen P; Fagard R; Staessen J; Verschueren LJ; Amery A
    Clin Pharmacol Ther; 1980 Sep; 28(3):310-5. PubMed ID: 6250759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin I-converting enzyme inhibitor, SQ 14225, in nomal men.
    Kono T; Ikeda F; Oseko F; Imura H; Endo J
    Endocrinol Jpn; 1979 Jun; 26(3):411-8. PubMed ID: 383475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of various doses of captopril on plasma aldosterone concentrations in patients with essential hypertension.
    Izumi Y; Honda M; Hatano M
    Endocrinol Jpn; 1982 Dec; 29(6):717-23. PubMed ID: 6763896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y; Honda M; Hatano M
    Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive mechanism of oral angiotensin I converting enzyme inhibitor (captopril) in renin-independent essential hypertension].
    Miyamori I; Takeda Y; Ikeda M; Koshida H; Yasuhara S; Morise T; Takimoto H; Takeda R; Nishino T
    Nihon Naibunpi Gakkai Zasshi; 1983 Jun; 59(6):907-17. PubMed ID: 6311635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
    Sassano P; Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A
    Am J Cardiol; 1982 Apr; 49(6):1574-6. PubMed ID: 6280486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of captopril on serum angiotensin-converting enzyme activity, the renin-aldosterone system and blood pressure in patients with sarcoidosis.
    Mizuno K; Gotoh M; Matsui J; Nagasawa S; Fukuchi S
    Tohoku J Exp Med; 1983 May; 140(1):107-8. PubMed ID: 6306866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
    Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
    Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
    Hashimoto H; Hiwada K; Kokubu T
    Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluctuations in the plasma angiotensin I converting enzyme activity during long-term treatment with captopril.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Acta Cardiol; 1982; 37(1):1-9. PubMed ID: 6282024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC
    Br Med J; 1979 Nov; 2(6198):1106-9. PubMed ID: 229941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of food on acute and chronic effects of captopril in essential hypertensive patients.
    Salvetti A; Pedrinelli R; Magagna A; Abdel-Haq B; Graziadei L; Taddei S; Stornello M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S25-9. PubMed ID: 2580172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
    Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system].
    Mizuno K; Gotoh M; Haruyama K; Hashimoto S; Toki T; Matsui J; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1620-9. PubMed ID: 6363144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.